Dr. Andrew J. P. Lewington is a Consultant Renal Physician and Honorary Associate Professor at Leeds Teaching Hospitals NHS Trust, where he is the clinical lead for AKI and a kidney transplant physician. He was an expert advisor to the NCEPOD Adding Insult to Injury AKI study and is the AKI lead for the Renal Association. He is the current Renal Association clinical guidelines chair and sits on the RA clinical affairs board.
Dr. Lewington chaired a multi-professional group to produce the Academy of Medical Royal Colleges AKI core competencies. He is the UK Kidney Research Consortium lead for AKI and is working to facilitate AKI research in the UK. He was co-supervisor of the first Nephrology MRC awarded a grant in West Yorkshire investigating markers of kidney transplant dysfunction. He is the West Yorkshire LCRN renal study lead and the Chief investigator on an NIHR Applied Programme to evaluate protein biomarkers in renal transplantation.
He is chair of the NHS England AKI Risk Workstream. He was a member of the NICE AKI and intravenous clinical guideline groups. Dr. Lewington is the co-chief investigator for the NIHR portfolio study investigating the role of recombinant alkaline phosphatase in the treatment of AKI in sepsis (£29m). He is a chief investigator for the NIHR portfolio study assessing the outcomes of patients with acute kidney injury in critical care.
Midnight Health Ltd specialises in helping innovative MedTech companies navigate the complex landscape of the NHS to introduce new products and advancements. With a focus on bringing innovative products and solutions to the NHS, our mission is to help these companies navigate the NHS, ensuring that their products are evaluated and adopted in a timely manner. We understand the importance of bridging the gap between innovative MedTech companies and the NHS, and we are dedicated to making that happen. Midnight Health provides a tailor-made approach to accessing the NHS, including market assessment and sales and marketing strategy development.
https://www.midnighthealth.co.uk
Kerrie Davies is an NIHR Clinical Lecturer, Principal Clinical Scientist, she was the Deputy Lead for Infection on the NIHR Leeds MedTech Invitro Diagnostics Cooperative (MIC), and is currently Co-lead for the Early Diagnosis and Personalised Care theme of the HealthTech Research Centre, and Deputy theme lead within the Infection and AMR theme of the NIHR Leeds Biomedical Research Centre (BRC), within the Healthcare Infections Research Group at Leeds Teaching Hospitals NHS Trust; Honorary Associate Professor of diagnostic for infectious disease at University of Leeds; Senior Scientific Advisor to the Office of the Chief Scientific Officer at NHS England; Co-chair Empower Leeds Women, and Education lead for the European Society of Clinical Microbiology and Infectious Disease study group committee for C. difficile. During the pandemic she was seconded first into DHSC, and then UKHSA, to lead on validating COVID-19 diagnostic assays, then contributing to writing and setting up, then operationalising new regulatory legislation (Coronavirus Test Device Approval 2021) for COVID-19 test devices.
Kerrie has been researching in vitro diagnostics for >20 years, both nationally and internationally, including defining the optimal C. difficile testing algorithm which was adopted in the UK and recommended in European, American, and Australasian testing guidelines. She has a passion for the impact of research on patients and healthcare, and in particular supporting Healthcare Scientists in research careers and was awarded CSO Healthcare Scientist of the year in 2021 for her work on COVID-19 diagnostics.
The HealthTech Innovation Incubator is a dedicated platform for HealthTech innovators focused on revolutionizing healthcare through technology. It offers opportunities for knowledge sharing on cutting-edge technologies, business strategies for scaling up HealthTech ventures, and networking with entrepreneurs, investors, and industry experts. Members can exchange valuable resources, receive support and mentorship, and collaborate with peers. Join us to be part of a vibrant community committed to driving innovation and shaping the future of healthcare.
Jane is an Associate Professor in Clinical Microbiology at the University of Leeds and a Clinical Scientist at Leeds Teaching Hospitals Trust. She was National Clinical Lead for AMR Diagnostics at NHS England from 2022-24.
Her research interests are in Healthcare associated infections, antimicrobial resistance and infection diagnostics. She is a strong advocate for the patient voice in research and healthcare, and of women and healthcare scientists in clinical academic careers. She is Co-Chair of the Empower Leeds Women Network.
MBBS MRCP (Nephrology) PhD @sunildaga23
Sunil is a Consultant Nephrologist at Leeds Teaching Hospitals NHS Trust and Honorary Senior Lecturer at the University of Leeds. He is the EDI lead for the NIHR HRC (Leeds) and his research interests are improving access to transplantation and improving kidney health. He has experience of working with industry on home digital technology, digital education and application of AI/ML in post transplantation outcomes.
He is an executive member of UK Organ Donation and Transplantation Research Network and is a Subject matter expert in clinical transplant immunology. He is a Health Equity Fellow at West Yorkshire Health Inequality Network and has experience of working with several VCSE organisations across the UK in reducing health inequity. He is a strong advocate of co-production in research and wants the unheard voice to be listened in research.
Naomi is an experienced management professional with a background in Biomaterials and Health Informatics. She has worked as a Programme Analyst and Project Manager for the NHS and is now the Programme Manager for the Early diagnosis and Personalised care theme (HRC). Her greatest desire is to contribute to the creation of cultures that are genuinely more inclusive. Everyone deserves a strong sense of belonging and she has been a dedicated advocate for this throughout her management career. Her technical skills aside – this is most important to her.
